Australia markets closed

Twist Bioscience Corp (0ME.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
23.95+0.09 (+0.38%)
As of 08:06AM CET. Market open.
Full screen
Previous close23.86
Open23.95
Bid23.60 x 280000
Ask24.44 x 190000
Day's range23.95 - 23.95
52-week range23.43 - 86.28
Volume0
Avg. volume12
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Twist Bioscience to Present at 5th Annual Evercore ISI HealthCONx Conference

    SOUTH SAN FRANCISCO, Calif., November 23, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will host a fireside chat and one-on-one meetings at the 5th Annual Evercore ISI HealthCONx Conference on Wednesday, November 30th at 4:20 p.m. Eastern Time.

  • Business Wire

    Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results

    SOUTH SAN FRANCISCO, Calif., November 18, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the fourth quarter and full year fiscal 2022 ended September 30, 2022.

  • Business Wire

    Twist Bioscience Addresses Misleading Short-Seller Report

    SOUTH SAN FRANCISCO, Calif., November 15, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today addressed a misleading short-seller report issued by Scorpion Capital.